Correction to: Drugs R D 10.1007/s40268-017-0209-5
In the Original Publication of the article, In Introduction part, 7th line, the value “5–100 nM” has been published incorrectly. The correct value should read as “Plasma concentration of 50–100 ng/ml”. In the Original Publication of the article, page 591, Table 2 has been published incorrectly. The corrected table is shown below:
Table 2.
Delivered treatment, dose reductions and interruptions
| Sunitinib 4/2 schedule | Sunitinib modified schedule | |
|---|---|---|
| Median time from start to switch, months (range) | 2.9 (1.4–16.5) | – |
| Median duration of treatment after switch, months (range) | – | 9.2 (0.5–32.4) |
| Mean actual daily dose intensity, mg (range) | 46.1 (20.8–50.0) | 44.3 (17.9–71.8) |
| Mean relative dose intensity, % (range) | 92.3 (42–100) | 88.7 (36–144) |
| Total cycles, number | 88 | 164 |
| Median cycles, number (range) | 2 (1–11) | 5 (1–20) |
| Patients with a dose reduction, number (%) | 3 (12) | 3 (12) |
| Patients with a dose interruption, number (%) | 7 (28) | 12 (48) |
| Number of dose interruptions corrected for number of cycles (%) | 0.10 (10) | 0.11 (11) |
| Patients still on treatment, number (%) | – | 2 (16) |